Interfering with TGFβ-induced Smad3 nuclear accumulation differentially affects TGFβ-dependent gene expression

Molecular Cancer

Volumn 2, Issue , 2003, Pages

  Lindemann, Ralph K ^a   Nordheim, Alfred ^a   Dittmer, Jürgen ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

Breast tumor; Ets factors; Invasiveness; PTHrP; Smad3

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; 4-(4-FLUOROPHENYL)-2-(4-HYDROXYPHENYL)-5-(4-PYRIDYL)IMIDAZOLE; DNA BINDING PROTEIN; IMIDAZOLE DERIVATIVE; MESSENGER RNA; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; SMAD3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UPREGULATION; WESTERN BLOTTING; ACTIVE TRANSPORT; BREAST TUMOR; CELL NUCLEUS; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PYRIDINES; RNA, MESSENGER; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0141443965     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-2-20     Document Type: Article

References (53)

1. Derynck R, Akhurst RJ and Balmain A TGF-beta signaling in tumor suppression and cancer progression Nat Genet 2001, 29:117-129
2. Massague J, Blain SW and Lo RS TGFbeta signaling in growth control, cancer, and heritable disorders Cell 2000, 103:295-309
3. Cui W, Fowlis DJ, Bryson S, Duffie E, Ireland H, Balmain A and Akhurst RJ TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice Cell 1996, 86:531-542
4. Akhurst RJ and Derynck R TGF-beta signaling in cancer - a double-edged sword Trends Cell Biol 2001, 11:S44-NaN
5. Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, Gulino A and Mackay AR Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity Int J Cancer 1998, 75:721-730
6. Duivenvoorden WC, Hirte HW and Singh G Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells Clin Exp Metastasis 1999, 17:27-34
7. Massague J How cells read TGF-beta signals Nat Rev Mol Cell Biol 2000, 1:169-178
8. Massague J and Wotton D Transcriptional control by the TGF-beta/Smad signaling system Embo J 2000, 19:1745-1754
9. Yoneda T Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone Eur J Cancer 1998, 34:240-245
10. Chirgwin JM and Guise TA Molecular mechanisms of tumor-bone interactions in osteolytic metastases Crit Rev Eukaryot Gene Expr 2000, 10:159-178
11. Guise TA Molecular mechanisms of osteolytic bone metastases Cancer 2000, 88:2892-2898
12. Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ and Adams JL Inhibition of p38 MAP kinase as a therapeutic strategy Immunopharmacology 2000, 47:185-201
13. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW and et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis Nature 1994, 372:739-746
14. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1 FEBS Lett 1995, 364:229-233
15. Ajizian SJ, English BK and Meals EA Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma J Infect Dis 1999, 179:939-944
16. Eyers PA, Craxton M, Morrice N, Cohen P and Goedert M Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution Chem Biol 1998, 5:321-328
17. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF and Olson BA Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542 Mol Pharmacol 2002, 62:58-64
18. Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, Harrington FP, Heer J, Kwon C, Lehr R, Mathur A, Olson BA, Weinstock J and Laping NJ Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5) J Med Chem 2002, 45:999-1001
19. Lindemann RK, Ballschmieter P, Nordheim A and Dittmer J Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism J Biol Chem 2001, 276:46661-46670
20. Pouliot F and Labrie C Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens Int J Cancer 1999, 81:98-103
21. Biggs JR and Kraft AS The role of the Smad3 protein in phorbol ester-induced promoter expression J Biol Chem 1999, 274:36987-36994
22. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH and ten Dijke P Identification of Smad7, a TGFbeta-inducible antagonist of TGFbeta signalling Nature 1997, 389:631-635
23. Chen CR, Kang Y and Massague J Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program Proc Natl Acad Sci U S A 2001, 98:992-999
24. Denissova NG, Pouponnot C, Long J, He D and Liu F Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter Proc Natl Acad Sci U S A 2000, 97:6397-6402
25. Massague J and Chen YG Controlling TGF-beta signaling Genes Dev 2000, 14:627-644
26. Schiffer M, Schiffer LE, Gupta A, Shaw AS, Roberts IS, Mundel P and Bottinger EP Inhibitory smads and tgf-Beta signaling in glomerular cells J Am Soc Nephrol 2002, 13:2657-2666
27. Blobe GC, Schiemann WP and Lodish HF Role of transforming growth factor beta in human disease N Engl J Med 2000, 342:1350-1358
28. Gooch JL, Herrera RE and Yee D The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells Cell Growth Differ 2000, 11:335-342
29. Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K and Libermann TA Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family Mol Cell Biol 1997, 17:4419-4433
30. Choi SG, Yi Y, Kim YS, Kato M, Chang J, Chung HW, Hahm KB, Yang HK, Rhee HH, Bang YJ and Kim SJ A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor J Biol Chem 1998, 273:110-117
31. von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D and Bottinger EP Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta J Biol Chem 2000, 275:11320-11326
32. Hua X, Miller ZA, Wu G, Shi Y and Lodish HF Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins Proc Natl Acad Sci U S A 1999, 96:13130-13135
33. Zawel L, Dai JL, Buckhaults P, Zhou S, Kinzler KW, Vogelstein B and Kern SE Human Smad3 and Smad4 are sequence-specific transcription activators Mol Cell 1998, 1:611-617
34. Zhang Y, Feng XH and Derynck R Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription Nature 1998, 394:909-913
35. Chen J, Baskerville C, Han Q, Pan ZK and Huang S Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells J Biol Chem 2001, 276:47901-47905
36. Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K and Nishida E Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression J Biol Chem 1999, 274:27161-27167
37. Huang S, New L, Pan Z, Han J and Nemerow GR Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity J Biol Chem 2000, 275:12266-12272
38. Kakonen SM, Selander KS, Chirgwin JM, Yin JJ, Burns S, Rankin WA, Grubbs BG, Dallas M, Cui Y and Guise TA Transforming Growth Factor-beta Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways J Biol Chem 2002, 277:24571-24578
39. Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J and Kahari VM Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase J Biol Chem 1999, 274:37292-37300
40. Bhowmick NA, Zent R, Ghiassi M, McDonnell M and Moses HL Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity J Biol Chem 2001, 276:46707-46713
41. Sementchenko VI and Watson DK Ets target genes: past, present and future Oncogene 2000, 19:6533-6548
42. Sharrocks AD The ETS-domain transcription factor family Nat Rev Mol Cell Biol 2001, 2:827-8
43. Dittmer J and Nordheim A Ets transcription factors and human disease Biochim Biophys Acta 1998, 1377:F1-11
44. Delannoy-Courdent A, Fauquette W, Dong-Le Bourhis XF, Boilly B, Vandenbunder B and Desbiens X Expression of c-ets-1 and uPA genes is associated with mammary epithelial cell tubulogenesis or neoplastic scattering Int J Dev Biol 1996, 40:1097-1108
45. Majka SM and McGuire PG Regulation of urokinase expression in the developing avian heart: a role for the Ets-2 transcription factor Mech Dev 1997, 68:127-137
46. Chang CH, Scott GK, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray JW and Benz CC ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis Oncogene 1997, 14:1617-1622
47. Neve R, Chang CH, Scott GK, Wong A, Friis RR, Hynes NE and Benz CC The epithelium-specific ets transcription factor ESX is associated with mammary gland development and involution Faseb J 1998, 12:1541-1550
48. Chang J, Lee C, Hahm KB, Yi Y, Choi SG and Kim SJ Over-expression of ERT(ESX/ESE-1/ELF3), an ets-related transcription factor, induces endogenous TGF-beta type II receptor expression and restores the TGF-beta signaling pathway in Hs578t human breast cancer cells Oncogene 2000, 19:151-154
49. Bai S and Cao X A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling J Biol Chem 2002, 277:4176-4182
50. Hocevar BA, Brown TL and Howe PH TGFb induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway Embo J 1999, 18:1345-1356
51. Itoh S, Thorikay M, Kowanetz M, Moustakas A, Itoh F, Heldin CH and Ten Dijke P Elucidation of Smad Requirement in Transforming Growth Factor-beta Type I Receptor-induced Responses J Biol Chem 2003, 278:3751-3761
52. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G and Atfi A Evidence for a role of the JNK cascade in Smad7-mediated apoptosis J Biol Chem 2001, 276:36797-36803
53. Blumenthal SG, Aichele G, Wirth T, Czernilofsky AP, Nordheim A and Dittmer J Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1 J Biol Chem 1999, 274:12910-12916